Selenized neural stem cell exosomes for CNS trauma repair
Open Access
- 9 January 2026
- journal article
- Published by OAE Publishing Inc. in Extracellular Vesicles and Circulating Nucleic Acids
- Vol. 7 (1) , 16-9
Abstract
A recent study on Cell Reports Medicine by Wang et al. introduces a hybrid exosome platform - selenized neural stem cell-derived exosomes (SeNExo) - that couples the biological functionality of neural stem cell exosomes with the antioxidant power of ultrasmall nanoselenium. SeNExo crosses the blood-brain barrier via apolipoprotein E (APOE)-lipoprotein receptor-associated protein-1 (LRP1) interaction, scavenges reactive oxygen species, and restores glial-neuron homeostasis. It demonstrates potent therapeutic efficacy in both traumatic brain injury and spinal cord injury mouse models. This work highlights a promising direction for engineering multifunctional, cell-free nanotherapeutics for central nervous system repair.Keywords
This publication has 5 references indexed in Scilit:
- Selenized neural stem cell-derived exosomes: A neotype therapeutic agent for traumatic injuries of the central nervous systemCell Reports Medicine, 2025
- Advances in research on biomaterials and stem cell/exosome-based strategies in the treatment of traumatic brain injuryActa Pharmaceutica Sinica B, 2025
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- How neural stem cells promote the repair of brain injury through immunoregulationChinese Medical Journal, 2020
- Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat StrokeCell, 2019